You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
奕瑞科技(688301.SH):已於今年年初完成部分CT球管的開發,並且部分CT球管進入送樣測試的階段

格隆匯5月23日丨奕瑞科技(688301.SH)在投資者互動平臺表示,公司已在2022年組建了CT球管團隊,團隊人員多爲在行業內有多年豐富經驗的人員,經過多年的研發,已於今年年初完成部分CT球管的開發,並且部分CT球管進入送樣測試的階段。按照醫療器械核心零部件正常的設備送樣、測試、註冊流程,從設備送樣到進入批量銷售階段,需要一到兩年的時間。關於此前商務部對美國及印度CT球管發起反傾銷調查的影響,重點關注後續的反傾銷調查結果及相應政策。目前,CT球管目前國產化率較低,有較大國產替代空間,公司也將加快CT球管的研發、測試及後續量產工作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account